|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 207/267 | |
| A61K 31/197 | |||
| A61K 31/4015 | |||
| A61P 25/08 | |||
| C07C 233/47 |
| (11) | Patento numeris | 3148969 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15803860.4 |
| Europos patento paraiškos padavimo data | 2015-06-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2015/050507 |
| Data | 2015-06-02 |
| (87) | Numeris | WO 2015/184542 |
| Data | 2015-12-10 |
| (30) | Numeris | Data | Šalis |
| 201462006515 P | 2014-06-02 | US |
| (72) |
ARAUJO, Joseph A., CA
ANDREWS, John S., CA
ANNEDI, Subhash C., CA
HIGGINS, Guy A., CA
MILGRAM, Norton W., CA
ESTEY, Paula J., CA
ROBINSON, Gary L. W. G., US
NAGIREDDY, Jaipal R., CA
|
| (73) |
Ketogen Inc.,
120 Carlton Street Suite 204, Toronto, Ontario M5A 4K2,
CA
|
| (54) | COMPOUNDS FOR THE TREATMENT OF SEIZURES AND OTHER CENTRAL NERVOUS SYSTEM DISORDERS AND CONDITIONS |
| COMPOUNDS FOR THE TREATMENT OF SEIZURES AND OTHER CENTRAL NERVOUS SYSTEM DISORDERS AND CONDITIONS |